​
​

Astria Therapeutics Ownership | Who Owns Astria Therapeutics?

OverviewForecastFinancialsChartTranscripts

Astria Therapeutics Ownership Summary

Astria Therapeutics is owned by 106.28% institutional investors, 0.47% insiders. Perceptive advisors is the largest institutional shareholder, holding 12.40% of ATXS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.77% of its assets in Astria Therapeutics shares.

ATXS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAstria Therapeutics106.28%0.47%-6.75%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.56M2.77%2.39K
Fidelity Small Cap Growth1.35M2.40%-3.54K
FIAM Small Cap Core CIT Cl B1.25M2.22%94.70K
iShares Russell 2000 ETF1.16M2.05%-2.60K
Fidelity Advisor Biotechnology I978.74K1.73%-
Fidelity Series Small Cap Opps824.80K1.46%-
FIAM Small Cap Core Composite734.29K1.30%734.29K
Heptagon Driehaus US Micro Cap Eq C$ Acc613.25K1.09%4.99K
Fidelity Select Biotechnology596.26K1.06%-
SPDR® S&P Biotech ETF588.73K1.04%6.50K

Recent Insider Transactions

DateNameRoleActivityValue
Apr 01, 2024Morabito Christopher Chief Medical OfficerSell$135.94K
Feb 01, 2024PERCEPTIVE ADVISORS LLC-Buy$30.00M
Jan 29, 2024Morabito Christopher Chief Medical OfficerSell$102.55K
Jan 26, 2024Morabito Christopher Chief Medical OfficerSell$8.81K
Dec 21, 2023PERCEPTIVE ADVISORS LLC-Buy$4.59M

Insider Transactions Trends

DateBuySell
2024 Q2-1
2024 Q112
2023 Q47-
2023 Q2--
2022 Q41-

ATXS Ownership FAQ

Who Owns Astria Therapeutics?

Astria Therapeutics shareholders are primarily institutional investors at 106.28%, followed by 0.47% insiders and -6.75% retail investors. The average institutional ownership in Astria Therapeutics's industry, Biotech Stocks , is 45.35%, which Astria Therapeutics exceeds.

Who owns the most shares of Astria Therapeutics?

Astria Therapeutics’s largest shareholders are Perceptive advisors (6.49M shares, 12.40%), Fmr (6.05M shares, 11.58%), and Ra capital management (5.04M shares, 9.64%). Together, they hold 33.62% of Astria Therapeutics’s total shares outstanding.

Does Blackrock own Astria Therapeutics?

Yes, BlackRock owns 6.73% of Astria Therapeutics, totaling 3.52M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.01M$. In the last quarter, BlackRock decreased its holdings by -67.913K shares, a -1.89% change.

Who is Astria Therapeutics’s biggest shareholder by percentage of total assets invested?

Fairmount funds management is Astria Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.65% of its assets in 3.55M Astria Therapeutics shares, valued at 32.34M$.

Who is the top mutual fund holder of Astria Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Astria Therapeutics shares, with 2.77% of its total shares outstanding invested in 1.56M Astria Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools